CIBC Private Wealth Group
GSK icon

CIBC Private Wealth Group’s GSK GSK Stock Holding History

CIBC Private Wealth Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$220K Sell
4,493
-741
-14% -$34.6K ﹤0.01% 1146
2025
Q3 		$226K Buy
5,234
+1,075
+26% +$42K ﹤0.01% 1130
2025
Q2 		$160K Sell
4,159
-1,910
-31% -$73K ﹤0.01% 1208
2025
Q1 		$207K Sell
6,069
-543
-8% -$19.9K ﹤0.01% 1069
2024
Q4 		$223K Sell
6,612
-3,758
-36% -$135K ﹤0.01% 1121
2024
Q3 		$424K Sell
10,370
-617
-6% -$25.2K ﹤0.01% 920
2024
Q2 		$425K Sell
10,987
-1,426
-11% -$60K ﹤0.01% 866
2024
Q1 		$527K Buy
12,413
+3,497
+39% +$144K ﹤0.01% 825
2023
Q4 		$330K Sell
8,916
-294
-3% -$10.6K ﹤0.01% 903
2023
Q3 		$334K Buy
+9,210
New +$327K ﹤0.01% 854
2022
Q2 		– Sell
-157
Closed -$9K – 1240
2022
Q1 		$9K Buy
+157
New +$8.53K ﹤0.01% 1148
2021
Q3 		– Sell
-13,647
Closed -$680K – 969
2021
Q2 		$680K Sell
13,647
-304
-2% -$14.6K ﹤0.01% 740
2021
Q1 		$622K Sell
13,951
-151
-1% -$6.85K ﹤0.01% 763
2020
Q4 		$649K Sell
14,102
-256
-2% -$11.8K ﹤0.01% 727
2020
Q3 		$676K Sell
14,358
-15,936
-53% -$798K ﹤0.01% 632
2020
Q2 		$1.54M Sell
30,294
-395
-1% -$20.3K 0.01% 413
2020
Q1 		$1.45M Sell
30,689
-1,379
-4% -$73.6K 0.01% 460
2019
Q4 		$1.88M Buy
32,068
+24,064
+301% +$1.34M 0.01% 478
2019
Q3 		$427K Sell
8,004
-3,855
-33% -$198K ﹤0.01% 714
2019
Q2 		$593K Buy
11,859
+209
+2% +$10.5K ﹤0.01% 678
2019
Q1 		$609K Sell
11,650
-8,668
-43% -$433K ﹤0.01% 681
2018
Q4 		$971K Sell
20,318
-14,156
-41% -$697K ﹤0.01% 572
2018
Q3 		$1.73M Buy
34,474
+2,180
+7% +$111K 0.01% 552
2018
Q2 		$1.63M Buy
32,294
+6,153
+24% +$310K 0.01% 556
2018
Q1 		$1.28M Sell
26,141
-3,837
-13% -$179K 0.01% 600
2017
Q4 		$1.33M Sell
29,978
-25,848
-46% -$1.19M 0.01% 602
2017
Q3 		$2.83M Buy
55,826
+9,421
+20% +$478K 0.01% 420
2017
Q2 		$2.5M Buy
46,405
+5,416
+13% +$289K 0.02% 357
2017
Q1 		$2.16M Buy
40,989
+1,023
+3% +$51.9K 0.01% 361
2016
Q4 		$1.92M Sell
39,966
-3,754
-9% -$185K 0.01% 369
2016
Q3 		$2.36M Buy
43,720
+3,114
+8% +$171K 0.02% 345
2016
Q2 		$2.2M Buy
40,606
+89
+0.2% +$4.69K 0.02% 354
2016
Q1 		$2.05M Sell
40,517
-2,641
-6% -$132K 0.02% 348
2015
Q4 		$2.18M Buy
43,158
+3,711
+9% +$189K 0.02% 347
2015
Q3 		$1.9M Sell
39,447
-770
-2% -$40.1K 0.02% 354
2015
Q2 		$2.1M Sell
40,217
-802
-2% -$45.2K 0.02% 369
2015
Q1 		$2.37M Sell
41,019
-2,159
-5% -$124K 0.02% 358
2014
Q4 		$2.31M Buy
43,178
+6,245
+17% +$349K 0.02% 357
2014
Q3 		$2.12M Sell
36,933
-1,338
-3% -$82K 0.02% 364
2014
Q2 		$2.56M Buy
38,271
+8,101
+27% +$548K 0.02% 340
2014
Q1 		$2M Buy
+30,170
New +$2.04M 0.02% 366

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIBC Private Wealth Group's GSK Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its GSK (GSK) stake by 14% in Q4 2025, selling an estimated $34.6K and leaving 4,493 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #1146.

CIBC Private Wealth Group first reported a position in GSK in Q1 2014 and has held it in 41 quarters since. The position peaked at $2.83M in Q3 2017. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • CIBC Private Wealth Group held 4,493 shares of GSK worth $220K as of Q4 2025.
  • CIBC Private Wealth Group sold 741 GSK shares in Q4 2025, an estimated $34.6K.
  • GSK made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1146 holding.
  • CIBC Private Wealth Group first reported a position in GSK in Q1 2014 and has held it in 41 quarters since.
  • CIBC Private Wealth Group's GSK position peaked at $2.83M in Q3 2017.
  • 995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.